(2023). Development of a Tumor-Derived Extracellular Vesicle Engineering Protocol for Targeted Chemotherapeutic: A Novel Experimental Model using Malignant Pleural Mesothelioma Cells.

Development of a Tumor-Derived Extracellular Vesicle Engineering Protocol for Targeted Chemotherapeutic: A Novel Experimental Model using Malignant Pleural Mesothelioma Cells

BURGIO, Stefano
2023-06-26

26-giu-2023
Malignant Pleural Mesothelioma; Extracellular Vesicles; Target Therapy
(2023). Development of a Tumor-Derived Extracellular Vesicle Engineering Protocol for Targeted Chemotherapeutic: A Novel Experimental Model using Malignant Pleural Mesothelioma Cells.
File in questo prodotto:
File Dimensione Formato  
Tesi final - Stefano Burgio_6_05_2023.pdf

embargo fino al 26/06/2025

Tipologia: Tesi di dottorato
Dimensione 2.14 MB
Formato Adobe PDF
2.14 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/595033
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact